EquityRoots
Pharmaceuticals
Healthcare · Pharmaceuticals · Long-term Compounder

Torrent Pharmaceuticals Limited

TORNTPHARM·4185.1·₹1.42L Cr·Listed 25 Nov 2002
Composite
66
Above median in Pharmaceuticals · Long-term Compounder
Rank7of 12
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and int…
Healthcare
Company description
Founded
1959
Headquarters
Ahmedabad, India
CEO / MD
Mr. Sanjay Gupta · President and CEO of Torrent Pharma USA
Major milestone
The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971.
What they do
Core products
products in various therapeutic areasincluding anti-diabeticanti-microbialcardiovascularurologygynecology
Target customers
Not explicitly disclosed
Global footprint
IndiaInternationalUnited StatesGermany
4 regions mentioned in disclosures
Shareholder breakup
Promoter
68.3%
FII
16.2%
DII
9.0%
Public
6.5%+0.1
As of Mar 202683811 holders
Read full description

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

Sourced from public company disclosures.
About
Torrent Pharmaceuticals Limited
IndustryPharmaceuticals & Biotechnology
SectorHealthcare
ClusterPharmaceuticals · Long-term Compounder
Market cap₹1.42L Cr
Listed25 Nov 2002
Price history24 years available
Fundamentals10 years available
Price history
TORNTPHARM · monthly close, 2002–2026
+52523%
30.0% CAGR · 24y
4,380.8+1,172.93 (+36.56%)1Y